School of Medicine


Showing 1-10 of 130 Results

  • Muriel Babey

    Muriel Babey

    Assistant Professor of Medicine (Endocrinology)

    BioMuriel Babey, M.D. is an Assistant Professor of Medicine in the Division of Endocrinology, Gerontology & Metabolism at Stanford University. She is a physician–scientist who specializes in metabolic bone disease and osteoporosis, with a focus on skeletal health during reproductive transitions and aging, as well as disorders of calcium and parathyroid metabolism.

    Originally from Switzerland, Dr. Babey earned her medical degree in Switzerland and completed fellowship training in Endocrinology at the University of California, San Francisco. During her postdoctoral training in the laboratory of Holly Ingraham at UCSF, her work focused on identifying CCN3 as a maternal brain–derived osteoanabolic hormone critical for lactation, uncovering a previously unrecognized neuroendocrine axis regulating bone formation and marrow adiposity.

    Dr. Babey directs a research program that integrates human cohort studies with mechanistic models to define endocrine pathways coordinating skeletal and metabolic resilience across reproductive transitions and aging. Her work centers on identifying secreted factors and interorgan communication networks that regulate bone health, with the goal of advancing translational strategies for osteoporosis and related metabolic diseases. Her research is supported by an NIH K08 award, and she is a recipient of the Endocrine Society Early Investigator Award and the ASBMR John Haddad Early Investigator Award.

  • Florian Bach

    Florian Bach

    Postdoctoral Scholar, Infectious Diseases

    BioI'm a molecular infection biologist by training, but shifted my focus from pathogens to hosts for my graduate research. During my PhD with Phil Spence in Edinburgh I studied both falciparum and vivax malaria using controlled human (re)infection models, collaborating closely with the groups of Simon Draper and Angela Minassian in Oxford. As a hybrid bioinformatician and experimentalist, I love systems immunology for answering complex questions about human health. For my postdoc, I study in how the human immune response to malaria evolves in infants as they become reinfected and age. I'm also interested in how such early-life immunological events, malaria and beyond, may affect vaccine responses and immune development later in life. I address this question by making use of a longitudinal study cohort of infants receiving monthly chemoprevention in Eastern Uganda, together with our collaborators at UC San Francisco and IDRC Uganda. I am a Global Health Postdoctoral Affiliate with the Stanford Center for Innovation in Global Health.

  • Adrian Matias Bacong

    Adrian Matias Bacong

    Affiliate, Medicine - Med/Family and Community Medicine

    BioAdrian Matias Bacong, PhD, MPH is a postdoctoral research scholar within the Stanford University School of Medicine - Division of Cardiovascular Medicine. His current projects evaluate the utility of racial correction factors in cardiovascular risk algorithms, such as pooled cohort equations. This project is funded through the American Heart Association. His research also explores the intersections of social factors on health, especially among Asian Americans.

    His work has been published in the Journal of Epidemiology and Community Health, Journal of Health and Social Behavior, Social Science and Medicine, the Journal of the American Heart Association, and the Journal of the American Medical Association. Dr. Bacong graduated with this PhD in Community Health Sciences from the UCLA Fielding School of Public Health in 2022 and received his MPH in Health Promotion and Behavioral Science from the San Diego State University School of Public Health in 2016.

  • Cameron Scott Bader

    Cameron Scott Bader

    Postdoctoral Scholar, Bone Marrow Transplantation

    BioMy research is focused on using preclinical models to develop novel therapies which improve outcomes for patients receiving allogeneic hematopoietic stem cell transplantation. Currently, my work aims to establish strategies to reduce the risk of relapse after allogeneic hematopoietic stem cell transplantation without exacerbating graft-versus-host disease or interfering with donor stem cell engraftment.

  • Adi badhwar

    Adi badhwar

    Affiliate, Computational Medicine

    BioBuilding healthcare technology products powered by deep-learning & big data from concept to scale